The TRAIL Decoy Receptor TRUNDD (DcR2, TRAIL-R4) Is Induced by Adenovirus-p53 Overexpression and Can Delay TRAIL-, p53-, and KILLER/DR5-Dependent Colon Cancer Apoptosis
Authors:
- E. Robert McDonaldEME. Robert McDonald
- M. Saeed SheikhMSM. Saeed Sheikh
- Albert J. FornaceAFAlbert J. Fornace
- Wafik S. El-DeiryWEWafik S. El-Deiry
Open Access
- 1 February 2000
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 1 (2) , 130-144
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- The antiapoptotic decoy receptor TRID/TRAIL-R3 is a p53-regulated DNA damage-inducible gene that is overexpressed in primary tumors of the gastrointestinal tractOncogene, 1999
- JNK/SAPK activity is not sufficient for anticancer therapy-induced apoptosis involving CD95-L, TRAIL and TNF-?International Journal of Cancer, 1999
- Death Receptors: Signaling and ModulationScience, 1998
- Regulation ofp53downstream genesSeminars in Cancer Biology, 1998
- The Novel Receptor TRAIL-R4 Induces NF-κB and Protects against TRAIL-Mediated Apoptosis, yet Retains an Incomplete Death DomainImmunity, 1997
- KILLER/DR5 is a DNA damage–inducible p53–regulated death receptor geneNature Genetics, 1997
- An Antagonist Decoy Receptor and a Death Domain-Containing Receptor for TRAILScience, 1997
- Apoptosis by Death FactorCell, 1997
- WAF1, a potential mediator of p53 tumor suppressionCell, 1993
- A novel domain within the 55 kd TNF receptor signals cell deathCell, 1993